Cystic Fibrosis Trial, Recruiting (NCT06560463)

Cystic Fibrosis Trial, Recruiting NCT06560463 Sponsor: Medical College of Wisconsin Condition: Cystic Fibrosis

Printed from Voxsanity (voxsanity.com.au) — NCT06560463 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cystic Fibrosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an adult who has been diagnosed with cystic fibrosis (CF) and are a patient at the Froedtert Multidisciplinary CF Clinic.
Your blood sugar levels are either normal or slightly higher than normal (but not diabetic), based on a sugar-tolerance test done in 2024.
You are in your usual good health at the time of the blood sugar tests and glucose monitor wear period.

Who may not be able to join:

You have already been diagnosed with cystic fibrosis-related diabetes (CFRD) and are taking medications that can raise blood sugar levels.
You have had an organ transplant.
You are currently pregnant.
You are unable or unwilling to wear a continuous glucose monitor (a small sensor that tracks blood sugar) for the full 10-day period required by the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 414-955-7040

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06560463

Sponsor: Medical College of Wisconsin

Phase: Not Applicable

Status: Recruiting

Condition: Cystic Fibrosis

Trial contact: 414-955-7040

More information: https://clinicaltrials.gov/study/NCT06560463

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an adult who has been diagnosed with cystic fibrosis (CF) and are a patient at the Froedtert Multidisciplinary CF Clinic.
Your blood sugar levels are either normal or slightly higher than normal (but not diabetic), based on a sugar-tolerance test done in 2024.
You are in your usual good health at the time of the blood sugar tests and glucose monitor wear period.

Who may not be able to join:

You have already been diagnosed with cystic fibrosis-related diabetes (CFRD) and are taking medications that can raise blood sugar levels.
You have had an organ transplant.
You are currently pregnant.
You are unable or unwilling to wear a continuous glucose monitor (a small sensor that tracks blood sugar) for the full 10-day period required by the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical College of Wisconsin

Registry

ClinicalTrials.gov

Start date

13 January 2025

Est. completion

1 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Blood glucose measurement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov